Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antineoplastic Agents, Phytogenic | 6 | 2020 | 616 | 1.500 |
Why?
|
Paclitaxel | 8 | 2020 | 1728 | 1.440 |
Why?
|
Drug Delivery Systems | 8 | 2024 | 2207 | 1.420 |
Why?
|
Nanoparticles | 8 | 2023 | 1964 | 1.110 |
Why?
|
Aerosols | 5 | 2020 | 633 | 1.010 |
Why?
|
Nasal Sprays | 1 | 2024 | 27 | 0.930 |
Why?
|
Nanotechnology | 3 | 2018 | 703 | 0.820 |
Why?
|
Melanoma, Experimental | 2 | 2014 | 558 | 0.710 |
Why?
|
Central Nervous System Diseases | 1 | 2024 | 518 | 0.670 |
Why?
|
Pulmonary Surfactants | 2 | 2018 | 169 | 0.660 |
Why?
|
Biomimetic Materials | 3 | 2018 | 170 | 0.650 |
Why?
|
Diphtheria Toxin | 1 | 2020 | 253 | 0.650 |
Why?
|
Nanocapsules | 3 | 2014 | 92 | 0.570 |
Why?
|
Urinary Bladder | 1 | 2024 | 1154 | 0.570 |
Why?
|
Endosomes | 1 | 2020 | 522 | 0.560 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1008 | 0.540 |
Why?
|
Phosphatidylserines | 3 | 2020 | 184 | 0.480 |
Why?
|
Nanospheres | 1 | 2014 | 20 | 0.480 |
Why?
|
Delayed-Action Preparations | 3 | 2020 | 967 | 0.460 |
Why?
|
Osteoarthritis | 1 | 2022 | 1051 | 0.440 |
Why?
|
Transport Vesicles | 1 | 2013 | 79 | 0.410 |
Why?
|
Drug Carriers | 5 | 2021 | 700 | 0.390 |
Why?
|
Administration, Inhalation | 4 | 2018 | 1154 | 0.390 |
Why?
|
Chitosan | 1 | 2013 | 138 | 0.390 |
Why?
|
Lipids | 2 | 2013 | 3316 | 0.380 |
Why?
|
Lung Diseases | 1 | 2018 | 1940 | 0.290 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2531 | 0.270 |
Why?
|
Lung Neoplasms | 4 | 2020 | 13451 | 0.260 |
Why?
|
Nanomedicine | 3 | 2021 | 286 | 0.250 |
Why?
|
Pharmaceutical Preparations | 2 | 2024 | 1084 | 0.230 |
Why?
|
Administration, Intravesical | 1 | 2024 | 88 | 0.220 |
Why?
|
Phosphatidylethanolamines | 2 | 2014 | 128 | 0.220 |
Why?
|
Biocompatible Materials | 3 | 2024 | 1682 | 0.220 |
Why?
|
Rats, Wistar | 4 | 2020 | 1884 | 0.210 |
Why?
|
Administration, Intranasal | 1 | 2024 | 482 | 0.200 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3733 | 0.200 |
Why?
|
Cell Line, Tumor | 8 | 2016 | 17075 | 0.190 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 254 | 0.190 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3421 | 0.190 |
Why?
|
Chondrocytes | 2 | 2018 | 799 | 0.180 |
Why?
|
Injections, Intra-Articular | 1 | 2022 | 279 | 0.180 |
Why?
|
Drug Synergism | 3 | 2014 | 1749 | 0.170 |
Why?
|
Sesquiterpenes | 1 | 2021 | 175 | 0.170 |
Why?
|
Animals | 16 | 2024 | 168759 | 0.170 |
Why?
|
Gene Transfer Techniques | 1 | 2024 | 1216 | 0.160 |
Why?
|
Apoptosis | 2 | 2014 | 9514 | 0.160 |
Why?
|
Ultrasonic Therapy | 1 | 2021 | 216 | 0.160 |
Why?
|
Reactive Oxygen Species | 2 | 2024 | 2140 | 0.150 |
Why?
|
Mice | 9 | 2024 | 81818 | 0.150 |
Why?
|
Pulmonary Surfactant-Associated Proteins | 1 | 2018 | 18 | 0.150 |
Why?
|
Inflammation | 1 | 2018 | 10850 | 0.150 |
Why?
|
Hydrogels | 3 | 2019 | 728 | 0.150 |
Why?
|
Triamcinolone Acetonide | 1 | 2018 | 105 | 0.140 |
Why?
|
Blood-Brain Barrier | 2 | 2021 | 1037 | 0.130 |
Why?
|
Particle Size | 2 | 2021 | 1631 | 0.130 |
Why?
|
Synovial Fluid | 1 | 2018 | 385 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5849 | 0.120 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 2014 | 40 | 0.120 |
Why?
|
Mice, Nude | 3 | 2020 | 3618 | 0.120 |
Why?
|
Tacrolimus | 1 | 2019 | 753 | 0.120 |
Why?
|
Hyaline Cartilage | 1 | 2014 | 10 | 0.120 |
Why?
|
Protein Transport | 1 | 2020 | 1938 | 0.120 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 510 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 580 | 0.110 |
Why?
|
Lung | 4 | 2020 | 10033 | 0.110 |
Why?
|
Prodrugs | 1 | 2016 | 273 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6364 | 0.110 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 272 | 0.100 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1377 | 0.100 |
Why?
|
Phosphorylcholine | 1 | 2012 | 151 | 0.100 |
Why?
|
Hemolysis | 1 | 2014 | 406 | 0.100 |
Why?
|
Rats | 4 | 2020 | 23707 | 0.090 |
Why?
|
Purines | 1 | 2014 | 615 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 22331 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 504 | 0.090 |
Why?
|
Vasodilation | 1 | 2014 | 970 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1652 | 0.090 |
Why?
|
Administration, Oral | 2 | 2020 | 4015 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2477 | 0.080 |
Why?
|
Surface Properties | 1 | 2013 | 1151 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1727 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1042 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4209 | 0.080 |
Why?
|
Humans | 20 | 2024 | 765956 | 0.080 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13648 | 0.080 |
Why?
|
Intestines | 1 | 2017 | 1906 | 0.080 |
Why?
|
Monocytes | 1 | 2018 | 2595 | 0.080 |
Why?
|
Imidazoles | 1 | 2014 | 1162 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1808 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5783 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4752 | 0.070 |
Why?
|
Cell Survival | 2 | 2014 | 5746 | 0.070 |
Why?
|
Nanostructures | 1 | 2012 | 548 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 934 | 0.070 |
Why?
|
HeLa Cells | 1 | 2013 | 3067 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2822 | 0.070 |
Why?
|
Regeneration | 1 | 2014 | 1517 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18294 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3540 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2429 | 0.060 |
Why?
|
Molecular Structure | 2 | 2021 | 1885 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5337 | 0.050 |
Why?
|
Neoplasms | 3 | 2024 | 22340 | 0.050 |
Why?
|
Pyridines | 1 | 2014 | 2888 | 0.050 |
Why?
|
Protein Binding | 1 | 2014 | 9296 | 0.050 |
Why?
|
Inhibitory Concentration 50 | 1 | 2020 | 461 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 399 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.040 |
Why?
|
Forelimb | 1 | 2019 | 115 | 0.040 |
Why?
|
Drug Implants | 1 | 2019 | 230 | 0.040 |
Why?
|
Glioblastoma | 1 | 2012 | 3459 | 0.040 |
Why?
|
Collagen Type IV | 1 | 2017 | 124 | 0.030 |
Why?
|
Drug Compounding | 1 | 2018 | 235 | 0.030 |
Why?
|
Swine, Miniature | 1 | 2019 | 971 | 0.030 |
Why?
|
Laminin | 1 | 2017 | 404 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2017 | 10429 | 0.030 |
Why?
|
Coated Materials, Biocompatible | 1 | 2017 | 314 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2016 | 406 | 0.030 |
Why?
|
Adhesiveness | 1 | 2014 | 52 | 0.030 |
Why?
|
Proteoglycans | 1 | 2017 | 793 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 144 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 148 | 0.030 |
Why?
|
Brain | 1 | 2021 | 27178 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11083 | 0.030 |
Why?
|
Alginates | 1 | 2014 | 247 | 0.030 |
Why?
|
Tissue Adhesives | 1 | 2014 | 177 | 0.020 |
Why?
|
Gelatin | 1 | 2014 | 227 | 0.020 |
Why?
|
Models, Animal | 1 | 2019 | 2120 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2017 | 2060 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 720 | 0.020 |
Why?
|
Female | 4 | 2014 | 396101 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3608 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 834 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11868 | 0.020 |
Why?
|
Drug Combinations | 1 | 2017 | 2077 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2012 | 9071 | 0.020 |
Why?
|
Injections | 1 | 2014 | 840 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2014 | 687 | 0.020 |
Why?
|
Drug Approval | 1 | 2018 | 818 | 0.020 |
Why?
|
Lactic Acid | 1 | 2016 | 1137 | 0.020 |
Why?
|
Materials Testing | 1 | 2014 | 868 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1241 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 18973 | 0.020 |
Why?
|
Collagen | 1 | 2017 | 2618 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3051 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8529 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5988 | 0.020 |
Why?
|
Graft Survival | 1 | 2019 | 3890 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2218 | 0.020 |
Why?
|
Prostate | 1 | 2016 | 1755 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2014 | 3089 | 0.020 |
Why?
|
Male | 4 | 2020 | 363691 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 2033 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2105 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2464 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65189 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3681 | 0.020 |
Why?
|
Graft Rejection | 1 | 2019 | 4499 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 3047 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1663 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3529 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2014 | 1855 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12131 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10729 | 0.010 |
Why?
|
Concepts
(164)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_